It was a pleasure to have Amy Flynn, Operations, Regulatory & Quality Officer at Delphine Dx, join the panel at TiE Jersey’s Healthcare & Life Sciences SIG event, From Breakthrough to Business: Commercializing Digital Health Technologies, hosted at the Johnson & Johnson Exchange in New Brunswick, NJ.
The conversation brought together an incredible group of founders, operators, and industry leaders who are all navigating the opportunities and challenges of bringing digital health innovations to market. From regulatory strategy and funding to scaling operations and the evolving role of AI in healthcare, the discussion was candid, practical, and full of valuable insights.
It was a rewarding evening and we were grateful for the opportunity to share our experiences, learn from fellow panelists, and connect with others who are equally passionate about translating innovation into meaningful patient impact.
Thank you to TiE Jersey and the organizing team for creating such a thoughtful forum and for including Delphine Dx in the conversation. We’re excited to continue building relationships, sharing knowledge, and advancing the future of healthcare together